2024 Q1 Form 10-K Financial Statement
#000109181824000027 Filed on March 22, 2024
Income Statement
Concept | 2024 Q1 | 2023 Q4 | 2023 |
---|---|---|---|
Revenue | |||
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | |||
YoY Change | |||
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $165.6K | $232.3K | |
YoY Change | -15.67% | -46.49% | |
Operating Profit | -$165.6K | -$232.3K | |
YoY Change | -15.67% | -46.49% | |
Interest Expense | |||
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | $3.000K | $12.00K | |
YoY Change | 0.0% | 0.0% | |
Pretax Income | |||
YoY Change | |||
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$165.6K | -$232.3K | |
YoY Change | -15.67% | -46.49% | |
Net Earnings / Revenue | |||
Basic Earnings Per Share | $0.00 | $0.00 | |
Diluted Earnings Per Share | $0.00 | $0.00 | |
COMMON SHARES | |||
Basic Shares Outstanding | 231.1M shares | 231.1M shares | 197.2M shares |
Diluted Shares Outstanding | 234.8M shares | 197.2M shares |
Balance Sheet
Concept | 2024 Q1 | 2023 Q4 | 2023 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | |||
YoY Change | |||
Cash & Equivalents | $259.2K | $108.00 | |
Short-Term Investments | |||
Other Short-Term Assets | |||
YoY Change | |||
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $259.2K | $108.00 | |
YoY Change | 3623.42% | -91.59% | |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $0.00 | $0.00 | |
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | $259.2K | $108.00 | |
Total Long-Term Assets | $0.00 | $0.00 | |
Total Assets | $259.2K | $108.00 | |
YoY Change | 3623.42% | -91.59% | |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | |||
YoY Change | |||
Accrued Expenses | |||
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | |||
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $83.88K | $9.900K | |
YoY Change | 3695.25% | -97.54% | |
LONG-TERM LIABILITIES | |||
Long-Term Debt | |||
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | |||
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $83.88K | $9.900K | |
Total Long-Term Liabilities | |||
Total Liabilities | $83.88K | $9.900K | |
YoY Change | 3695.25% | -97.54% | |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$1.032M | -$866.0K | |
YoY Change | 24.28% | 36.66% | |
Common Stock | $236.9K | $231.1K | |
YoY Change | 2.52% | 164.11% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $175.3K | -$9.792K | |
YoY Change | |||
Total Liabilities & Shareholders Equity | $259.2K | $108.00 | |
YoY Change | 3623.42% | -91.59% |
Cashflow Statement
Concept | 2024 Q1 | 2023 Q4 | 2023 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$165.6K | -$232.3K | |
YoY Change | -15.67% | -46.49% | |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$91.62K | -$22.59K | |
YoY Change | 190777.08% | -43.94% | |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | |||
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $350.7K | $21.41K | |
YoY Change | -46.31% | ||
NET CHANGE | |||
Cash From Operating Activities | -$91.62K | -$22.59K | |
Cash From Investing Activities | |||
Cash From Financing Activities | $350.7K | $21.41K | |
Net Change In Cash | $259.1K | -$1.176K | |
YoY Change | -539847.92% | 182.69% | |
FREE CASH FLOW | |||
Cash From Operating Activities | -$91.62K | -$22.59K | |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000894501 | |
CY2023Q4 | grhi |
Accrued Board Of Director Compensation
AccruedBoardOfDirectorCompensation
|
usd | |
CY2023 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
usd | |
CY2022 | grhi |
Common Stock Issued For Board Of Director And Consulting Services
CommonStockIssuedForBoardOfDirectorAndConsultingServices
|
usd | |
CY2022 | grhi |
Common Stock Issued To Prepay Director For Payment Of Operating Expenses
CommonStockIssuedToPrepayDirectorForPaymentOfOperatingExpenses
|
usd | |
CY2023 | grhi |
Increase Decrease In Accrued Board Of Directors Compensation
IncreaseDecreaseInAccruedBoardOfDirectorsCompensation
|
usd | |
CY2023 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | |
CY2023 | us-gaap |
Interest Paid
InterestPaid
|
usd | |
CY2022 | us-gaap |
Interest Paid
InterestPaid
|
usd | |
CY2023 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
usd | |
CY2022 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
usd | |
CY2023 | us-gaap |
Revenues
Revenues
|
usd | |
CY2022 | us-gaap |
Revenues
Revenues
|
usd | |
CY2023 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
usd | |
CY2022 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
usd | |
CY2023 | us-gaap |
Gross Profit
GrossProfit
|
usd | |
CY2022 | us-gaap |
Gross Profit
GrossProfit
|
usd | |
CY2023 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2023 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2023 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023 | dei |
Entity File Number
EntityFileNumber
|
000-56304 | |
CY2023 | dei |
Entity Registrant Name
EntityRegistrantName
|
GOLD ROCK HOLDINGS, INC. | |
CY2023 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | |
CY2023 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
87-0434297 | |
CY2023 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
2020 General Booth Blvd. | |
CY2023 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 230 | |
CY2023 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Virginia Beach | |
CY2023 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
VA | |
CY2023 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
23454 | |
CY2023 | dei |
Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
|
false | |
CY2023 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2023 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2023 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
false | |
CY2023 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2023 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2023Q2 | dei |
Entity Public Float
EntityPublicFloat
|
25572691 | usd |
CY2024Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
231053636 | shares |
CY2023Q4 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2023Q4 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2023Q4 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2023Q4 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false | |
CY2023 | dei |
Auditor Name
AuditorName
|
BF Borgers CPA PC | |
CY2023 | dei |
Auditor Firm
AuditorFirmId
|
5041 | |
CY2023 | dei |
Auditor Location
AuditorLocation
|
Lakewood, CO | |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
108 | usd |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1284 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
108 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
1284 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
108 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
1284 | usd |
CY2023Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
9900 | usd |
CY2022Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
372175 | usd |
CY2022Q4 | grhi |
Accrued Board Of Director Compensation
AccruedBoardOfDirectorCompensation
|
31000 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
9900 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
403175 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
9900 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
403175 | usd |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
850000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
850000000 | shares |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-866037 | usd |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
231053636 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
231053636 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
87482208 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
87482208 | shares |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
231053 | usd |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
87482 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
625192 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
144353 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-633726 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-9792 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-401891 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
108 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1284 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-232311 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-434182 | usd |
CY2022 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
1000 | usd |
CY2023 | grhi |
Common Stock Issued For Board Of Director And Consulting Services
CommonStockIssuedForBoardOfDirectorAndConsultingServices
|
172000 | usd |
CY2023 | grhi |
Common Stock Issued To Prepay Director For Payment Of Operating Expenses
CommonStockIssuedToPrepayDirectorForPaymentOfOperatingExpenses
|
29000 | usd |
CY2023 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
8725 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
362890 | usd |
CY2022 | grhi |
Increase Decrease In Accrued Board Of Directors Compensation
IncreaseDecreaseInAccruedBoardOfDirectorsCompensation
|
-30000 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-22586 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-40292 | usd |
CY2023 | us-gaap |
Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
|
21410 | usd |
CY2022 | us-gaap |
Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
|
39876 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
21410 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
39876 | usd |
CY2023 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-1176 | usd |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-416 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1284 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1700 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
108 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1284 | usd |
CY2023 | us-gaap |
Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
|
170000 | usd |
CY2022 | us-gaap |
Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
|
30000 | usd |
CY2023 | grhi |
Consulting Fees Expenses
ConsultingFeesExpenses
|
12000 | usd |
CY2022 | grhi |
Consulting Fees Expenses
ConsultingFeesExpenses
|
362500 | usd |
CY2023 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
50311 | usd |
CY2022 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
41682 | usd |
CY2023 | us-gaap |
Operating Expenses
OperatingExpenses
|
232311 | usd |
CY2022 | us-gaap |
Operating Expenses
OperatingExpenses
|
434182 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-232311 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-434182 | usd |
CY2023 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
197225847 | shares |
CY2023 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
197225847 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
87461386 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
87461386 | shares |
CY2023 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.00 | |
CY2023 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.00 | |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.00 | |
CY2022 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.00 | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-8585 | usd |
CY2022 | grhi |
Capital Contributions Director
CapitalContributionsDirector
|
39876 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
1000 | usd |
CY2023 | grhi |
Common Stock Issued For Accounts Payable And Accrued Expenses
CommonStockIssuedForAccountsPayableAndAccruedExpenses
|
402000 | usd |
CY2023 | grhi |
Common Stock Issued To Prepay Director For Payment Of Operating Expense
CommonStockIssuedToPrepayDirectorForPaymentOfOperatingExpense
|
29000 | usd |
CY2023 | grhi |
Common Stock Issued For Board Of Director Consulting Services
CommonStockIssuedForBoardOfDirectorConsultingServices
|
172000 | usd |
CY2023 | grhi |
Capital Contributions Director
CapitalContributionsDirector
|
21410 | usd |
CY2023 | us-gaap |
Profit Loss
ProfitLoss
|
-232311 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-9792 | usd |
CY2023 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_843_eus-gaap--UseOfEstimates_z4FfBd2vS5s5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_86F_zFrZ7AIE5PF5">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> | |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-866037 | usd |
CY2023Q4 | grhi |
Working Capital
WorkingCapital
|
9792 | usd |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
231053636 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
231053636 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
87482208 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
87482208 | shares |
CY2023 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
40952381 | shares |
CY2023 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
172000 | usd |
CY2023 | grhi |
Common Stock Issued For Consulting And Director Compensation Shares
CommonStockIssuedForConsultingAndDirectorCompensationShares
|
6904761 | shares |
CY2023 | grhi |
Common Stock Issued For Consulting And Director Compensation
CommonStockIssuedForConsultingAndDirectorCompensation
|
29000 | usd |
CY2022 | grhi |
Common Stock Issued For Professional Services Shares
CommonStockIssuedForProfessionalServicesShares
|
100000 | shares |
CY2022 | grhi |
Common Stock Issued For Professional Services
CommonStockIssuedForProfessionalServices
|
1000 | usd |
CY2023 | us-gaap |
Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
|
50410 | usd |
CY2022 | us-gaap |
Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
|
39876 | usd |
CY2023 | grhi |
Common Stock Issued To Prepay Director For Payment Of Operating Expenses
CommonStockIssuedToPrepayDirectorForPaymentOfOperatingExpenses
|
29000 | usd |
CY2023 | grhi |
Stock Issuance To Reimburse
StockIssuanceToReimburse
|
0.0042 | |
CY2023 | us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
21410 | usd |
CY2022 | us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
39876 | usd |
CY2023 | grhi |
Agreement Monthly Charges
AgreementMonthlyCharges
|
1000 | usd |
CY2023 | us-gaap |
Other Expenses
OtherExpenses
|
12000 | usd |
CY2022 | us-gaap |
Other Expenses
OtherExpenses
|
12000 | usd |
CY2023Q4 | grhi |
Accounts Payable
AccountsPayable
|
9000 | usd |
CY2022Q4 | grhi |
Accounts Payable
AccountsPayable
|
21000 | usd |
CY2023 | us-gaap |
Related Party Transaction Description Of Transaction
RelatedPartyTransactionDescriptionOfTransaction
|
The Company had a 5 year compensation agreement with its Board Chairman beginning January 1, 2022 and ending on December 31, 2026. Compensation was an annual fee of $30,000, due in the following month of January. | |
CY2022 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
30000 | usd |
CY2022Q4 | grhi |
Accrued Board Of Director Compensation
AccruedBoardOfDirectorCompensation
|
31000 | usd |
CY2028Q4 | grhi |
Agreement Amount Payable
AgreementAmountPayable
|
95000 | usd |
CY2023Q1 | grhi |
Agreement Amount Payable
AgreementAmountPayable
|
75000 | usd |
CY2023 | grhi |
Board Of Director Compensation
BoardOfDirectorCompensation
|
170000 | usd |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
850000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
850000000 | shares |